asenapine, nateglinide. Minor/Significance Unknown. Minor (1)imipramine increases effects of nateglinide by pharmacodynamic synergism. Thiazide dosage >50 mg/day may increase blood glucose. Antidiabetic agents are often used in combination; dosage adjustments may be required when initiating or discontinuing antidiabetic agents. testosterone increases effects of nateglinide by pharmacodynamic synergism. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Use Caution/Monitor. Does Nateglinide interact with other drugs you are taking? Monitor Closely (1)St John's Wort will decrease the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. Background Nateglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). Inducers of CYP2C9 decrease levels of nateglinide by increasing its metabolism. Warnings Elvitegravir is a moderate CYP2C9 inducer. nateglinide, insulin glargine. fluoxymesterone increases effects of nateglinide by pharmacodynamic synergism. Minor/Significance Unknown. To view formulary information first create a list of plans. Minor (1)mesterolone increases effects of nateglinide by pharmacodynamic synergism. Tell your doctor right away if you have symptoms of high or low blood sugar. Use Caution/Monitor. peginterferon alfa 2b decreases levels of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor.nateglinide will increase the level or effect of etravirine by affecting hepatic enzyme CYP2C9/10 metabolism. Avoid or Use Alternate Drug. Minor/Significance Unknown. Minor/Significance Unknown. gymnema increases effects of nateglinide by pharmacodynamic synergism. Use Caution/Monitor. Gatifloxacin is most likely to produce dysglycemia; moxifloxacin is least likely. Minor (1)cornsilk increases effects of nateglinide by pharmacodynamic synergism. Monitor Closely (1)cimetidine will increase the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. ephedrine decreases effects of nateglinide by pharmacodynamic antagonism. Monitor Closely (1)nateglinide, insulin regular human. Use Caution/Monitor. Minor/Significance Unknown. sulfamethoxazole will increase the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. Adverse effects. Based on the mechanism of action, bexarotene capsules may increase the action of insulin enhancing agents, resulting in hypoglycemia. gotu kola increases effects of nateglinide by pharmacodynamic synergism. Minor (1)nateglinide will increase the level or effect of flurbiprofen by affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown. Monitor Closely (2)nateglinide will increase the level or effect of phenytoin by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor. Discuss the risks and benefits of different treatments (such as diet, exercise, and medications including insulin). nateglinide will increase the level or effect of meloxicam by affecting hepatic enzyme CYP2C9/10 metabolism. Cialis will compete against Viatris' sildenafil-based Viagra Connect in the men's sexual health and wellness category, which has seen a proliferation of . amiodarone will increase the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. Minor (1)eucalyptus increases effects of nateglinide by pharmacodynamic synergism. Use Caution/Monitor. Antidiabetic agents are often used in combination; dosage adjustments may be required when initiating or discontinuing antidiabetic agents. affecting hepatic enzyme CYP2C9/10 metabolism. clarithromycin decreases levels of nateglinide by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Monitor Closely (1)clozapine, nateglinide. Coadministration may reduce nateglinide's hypoglycemic action. elvitegravir/cobicistat/emtricitabine/tenofovir DF decreases levels of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. Keep all medical and lab appointments. Quinolone antibiotic administration may result in hyper- or hypoglycemia. Gatifloxacin is most likely to produce dysglycemia; moxifloxacin is least likely. Other symptoms of low blood sugar such as dizziness, hunger, or sweating are unaffected by these drugs.Other medications can affect the results of urine tests for sugar or ketones. Minor/Significance Unknown. bexarotene increases effects of nateglinide by pharmacodynamic synergism. Compare formulary status to other drugs in the same class. tipranavir decreases effects of nateglinide by Other (see comment). pentobarbital will decrease the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. Theoretical interaction. Use Caution/Monitor. Monitor Closely (1)sulfisoxazole increases levels of nateglinide by plasma protein binding competition. Interaction especially seen in the treatment of hypokalemia. Comment: Reports of hyperglycemia due to insulin resistance with protease inhibitors. Use Caution/Monitor. Some sulfonylureas may produce a disulfiram like rxn. Other (see comment). Minor/Significance Unknown. ticlopidine will increase the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. (See also Side Effects section.) Consider reducing the dose when concomitantly using CYP2C9 substrates. Avoid or Use Alternate Drug. Minor/Significance Unknown. nateglinide, dapagliflozin. Use Caution/Monitor. This medicine does not help patients who have insulin-dependent or type 1 diabetes. Use Caution/Monitor. Minor/Significance Unknown. Monitor Closely (1)bexagliflozin, nateglinide. miconazole vaginal will increase the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. nateglinide, insulin degludec/insulin aspart. Either increases effects of the other by pharmacodynamic synergism. Minor/Significance Unknown. Minor (1)gymnema increases effects of nateglinide by pharmacodynamic synergism. Carefully follow the medication treatment plan, meal plan, and exercise program your doctor has recommended.Check your blood sugar regularly as directed by your doctor. Monitor Closely (1)liotrix decreases effects of nateglinide by pharmacodynamic antagonism. . fludrocortisone decreases effects of nateglinide by pharmacodynamic antagonism. Minor (1)potassium chloride increases effects of nateglinide by pharmacodynamic synergism. hydrochlorothiazide decreases effects of nateglinide by pharmacodynamic antagonism. Minor (1)maprotiline increases effects of nateglinide by pharmacodynamic synergism. Minor (1)testosterone topical increases effects of nateglinide by pharmacodynamic synergism. Nateglinide, USP is an oral blood glucose-lowering drug of the glinide class. Lowering the insulin secretagogue dose may reduce hypoglycemia risk. Consult your doctor or pharmacist for more information. Minor/Significance Unknown. Coadministration may reduce nateglinide's hypoglycemic action. Consider a lower dose of insulin secretagogue to avoid hypoglycemia when coadministered with bexagliflozin. Use Caution/Monitor. Monitor Closely (1)nateglinide will increase the level or effect of parecoxib by affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown. nateglinide will increase the level or effect of fosphenytoin by affecting hepatic enzyme CYP2C9/10 metabolism. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. bendroflumethiazide decreases effects of nateglinide by pharmacodynamic antagonism. Minor (1)metolazone decreases effects of nateglinide by pharmacodynamic antagonism. elvitegravir/cobicistat/emtricitabine/tenofovir DF, insulin isophane human/insulin regular human, triamcinolone acetonide injectable suspension, Use caution in patients with risk of severe hypoglycemia: elderly, malnourished, adrenal or pituitary insufficiency, hepatic insufficiency, Glinides can cause hypoglycemia; severe hypoglycemia can cause seizures, may be life-threatening or cause death, Hypoglycemia can impair concentration ability and reaction time; this may place an individual and others at risk in situations where these abilities are important (eg, driving or operating other machinery), Hypoglycemia can happen suddenly, and symptoms may differ in each individual and change over time in the same individual, Symptomatic awareness of hypoglycemia may be less pronounced in patients with longstanding diabetes, in patients with diabetic neuropathy (nerve disease), in patients using medications that block the sympathetic nervous system (eg, beta-blockers), or in patients who experience recurrent hypoglycemia, Factors which may increase risk of hypoglycemia include changes in meal pattern (eg, macronutrient content), changes in level of physical activity, changes to coadministered medication, and concomitant use with other antidiabetic agents, Patients with renal or hepatic impairment may be at higher risk of hypoglycemia; clinical Pharmacology; patients should take the medication before meals and be instructed to skip the dose if a meal is skipped, Patients and caregivers must be educated to recognize and manage hypoglycemia; self-monitoring of blood glucose plays an essential role in the prevention and management of hypoglycemia; in patients at higher risk for hypoglycemia and patients who have reduced symptomatic awareness of hypoglycemia, increased frequency of blood glucose monitoring recommended, In animal reproduction studies, there was no teratogenicity in rats and rabbits administered oral nateglinide during organogenesis at approximately 27 and 8 times maximum recommended human dose (MRHD), respectively, based on body surface area (BSA). Use Caution/Monitor. Medscape Education, Nocardia pseudobrasiliensis Co-infection in SARS-CoV-2 Patients, encoded search term (nateglinide (Starlix)) and nateglinide (Starlix), Walking Lowers CVD Risk in Patients With Impaired Glucose Tolerance, USPSTF Evidence Review Supports Prediabetes Screening, Insulin sensitizers slash PAD risk in BARI 2D analysis, Medscape Endocrinologist Wealth & Debt Report 2021, Skill Checkup: A 65-Year-Old Man With Established Type 2 Diabetes, Hypertension, Hyperlipidemia, and New-Onset Chest Pain. Either increases effects of the other by pharmacodynamic synergism. nateglinide will increase the level or effect of etravirine by affecting hepatic enzyme CYP2C9/10 metabolism. Monitor Closely (1)lisdexamfetamine decreases effects of nateglinide by pharmacodynamic antagonism. Either increases effects of the other by pharmacodynamic synergism. Minor/Significance Unknown. Monitor Closely (1)fluoxetine will increase the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor. Monitor Closely (1)bitter melon increases effects of nateglinide by pharmacodynamic synergism. consider incr. provider for the most current information. Use Caution/Monitor. Use Caution/Monitor. paliperidone, nateglinide. Very Important. May inhibit the conversion of losartan to its active metabolite E-3174. Monitor Closely (1)bexarotene increases effects of nateglinide by pharmacodynamic synergism. Monitor Closely (1)felbamate will increase the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. somatropin decreases effects of nateglinide by pharmacodynamic antagonism. Risk of hypoglycemia. Consult your doctor before breast-feeding. Sparsentan (a CYP2C9 inducer) decreases exposure of CYP2C9 substrates and reduces efficacy related to these substrates. Minor/Significance Unknown. Use Caution/Monitor. Antidiabetic agents are often used in combination; dosage adjustments may be required when initiating or discontinuing antidiabetic agents. Coadministration of insulin secretagogues with GLP-1 agonists may increase hypoglycemia risk. Minor/Significance Unknown. Use Caution/Monitor. If this effect lasts or gets worse, tell your doctor or pharmacist promptly. Use Caution/Monitor. Use Caution/Monitor. If you don't have these reliable forms of glucose, raise your blood sugar quickly by eating a quick source of sugar such as table sugar, honey, candy, or drinking a glass of fruit juice or non-diet soda. Quinolone antibiotic administration may result in hyper- or hypoglycemia. Monitor Closely (1)indinavir decreases effects of nateglinide by Other (see comment). Theoretical interaction. Antidiabetic agents are often used in combination; dosage adjustments may be required when initiating or discontinuing antidiabetic agents. oxymetholone increases effects of nateglinide by pharmacodynamic synergism. Symptoms may include chills, cold sweat, dizziness, drowsiness, shaking, fast heartbeat, weakness, headache, fainting, tingling of the hands or feet, or hunger. Drug interaction is defined as the interference of effects of one drug by the coadministered drugs, nutrients (food), herbs, alcohol or tobacco smoke. Use Caution/Monitor. Modify Therapy/Monitor Closely. Antidiabetic agents are often used in combination; dosage adjustments may be required when initiating or discontinuing antidiabetic agents. Increased risk of hypoglycemia (theoretical interaction). Elvitegravir is a moderate CYP2C9 inducer. quetiapine, nateglinide. It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to cells of the pancreas to stimulate insulin release. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. Coadministration of metreleptin with insulin and/or insulin secretagogues (eg, sulfonylureas, meglitinide derivatives) may increase risk for hypoglycemia; may require lower dose of insulin or insulin secretagogue. Monitor Closely (1)peginterferon alfa 2b decreases levels of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. During pregnancy, this medication should be used only when clearly needed. Use Caution/Monitor. Minor/Significance Unknown. Minor/Significance Unknown. Minor/Significance Unknown. If you notice other effects not listed above, contact your doctor or pharmacist. Use Caution/Monitor. Monitor Closely (1)semaglutide, nateglinide. Select a condition to view a list of medication options. Either increases effects of the other by pharmacodynamic synergism. Either increases effects of the other by pharmacodynamic synergism. Monitor Closely (1)bosentan will decrease the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. Nateglinide, an amino acid derivative of D-phenylalanine, stimulates the secretion of insulin by binding to the ATP potassium channels in pancreatic beta cells. Monitor blood glucose levels carefully. Theoretical interaction. Many people using this medication do not have serious side effects. lurasidone, nateglinide. Use Caution/Monitor. vanadium increases effects of nateglinide by pharmacodynamic synergism. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Minor (1)dexamethasone decreases effects of nateglinide by pharmacodynamic antagonism. Nateglinide may also be used for purposes not listed in this medication guide. Use Caution/Monitor. Minor/Significance Unknown. Do not drive, use machinery, or do any activity that requires alertness or clear vision until you are sure you can perform such activities safely. Corticosteroids may diminish hypoglycemic effect of antidiabetic agents. chlorthalidone decreases effects of nateglinide by pharmacodynamic antagonism. Gatifloxacin is most likely to produce dysglycemia; moxifloxacin is least likely. nateglinide will increase the level or effect of ibuprofen by affecting hepatic enzyme CYP2C9/10 metabolism. Coadministration may reduce nateglinide's hypoglycemic action. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Avoid alcohol. Comment: Reports of hyperglycemia due to insulin resistance with protease inhibitors. Risk of hypoglycemia. Monitor Closely (1)miconazole vaginal will increase the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Minor/Significance Unknown. epinephrine decreases effects of nateglinide by pharmacodynamic antagonism. Comment: Reports of hyperglycemia due to insulin resistance with protease inhibitors. Minor/Significance Unknown. Monitor Closely (1)levofloxacin increases effects of nateglinide by pharmacodynamic synergism. Ozempic (semaglutide) is a once-weekly injection used to treat Type 2 diabetes. Either increases effects of the other by pharmacodynamic synergism. Other (see comment). Minor (1)clomipramine increases effects of nateglinide by pharmacodynamic synergism. Use Caution/Monitor. nateglinide will increase the level or effect of losartan by affecting hepatic enzyme CYP2C9/10 metabolism. Based on the mechanism of action, bexarotene capsules may increase the action of insulin enhancing agents, resulting in hypoglycemia. shark cartilage increases effects of nateglinide by pharmacodynamic synergism. Either increases effects of the other by pharmacodynamic synergism. Promptly consult your doctor or pharmacist. Minor (1)cortisone decreases effects of nateglinide by pharmacodynamic antagonism. Use Caution/Monitor. based on body surface area). Use Caution/Monitor. Minor (1)forskolin increases effects of nateglinide by pharmacodynamic synergism. When patients are administered peginterferon alpha-2b with CYP2C9 substrates, the therapeutic effect of these drugs may be altered. Minor/Significance Unknown. Interaction especially seen in the treatment of hypokalemia. Use Caution/Monitor. Minor (1)nateglinide will increase the level or effect of diclofenac by affecting hepatic enzyme CYP2C9/10 metabolism. Monitor Closely (1)aripiprazole, nateglinide. Discuss the risks and benefits of different treatments (such as diet, exercise, and medications including insulin).It is unknown if this drug passes into breast milk. Hypoglycemia risk increased. Minor/Significance Unknown. Minor/Significance Unknown. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. danazol increases effects of nateglinide by pharmacodynamic synergism. Monitor Closely (1)pseudoephedrine decreases effects of nateglinide by pharmacodynamic antagonism. Gatifloxacin is most likely to produce dysglycemia; moxifloxacin is least likely. Theoretical interaction. Lowering the insulin secretagogue dose may reduce hypoglycemia risk. Coadministration of baricitinib with strong organic anion transporter 3 (OAT3) inhibitors is not recommended. . . Coadministration may reduce nateglinide's hypoglycemic action. Minor/Significance Unknown. alogliptin, nateglinide. Minor (1)potassium citrate increases effects of nateglinide by pharmacodynamic synergism. jaundice (yellowing of the skin or eyes). Consult drug interactions database for . Coadministration may reduce nateglinide's hypoglycemic action. commonly, these are generic drugs. Monitor Closely (1)saquinavir decreases effects of nateglinide by Other (see comment). Nateglinide is most effective if taken 1 to 10 minutes before a meal. Either increases effects of the other by pharmacodynamic synergism. Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Consider a lower dose of insulin or insulin secretagogue to avoid hypoglycemia when coadministered with ertugliflozin. Use Caution/Monitor. Increased risk of hypoglycemia (theoretical interaction). nateglinide dose: combo may decr. Minor/Significance Unknown. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. Monitor Closely (1)omeprazole will increase the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. Interaction especially seen in the treatment of hypokalemia. Nateglinide can cause low blood sugar (hypoglycemia) especially if you are taking other medicines for diabetes. fluvoxamine will increase the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. Minor (1)tongkat ali increases effects of nateglinide by pharmacodynamic synergism. Thiazide dosage >50 mg/day may increase blood glucose. darunavir decreases effects of nateglinide by Other (see comment). Discuss a plan with your doctor for managing your blood sugar while pregnant. Use Caution/Monitor. commonly, these are "non-preferred" brand drugs or specialty Rev. Coadministration may reduce nateglinide's hypoglycemic action. Monitor Closely (1)ertugliflozin, nateglinide. nateglinide, insulin aspart. ritonavir decreases effects of nateglinide by Other (see comment). eltrombopag increases levels of nateglinide by decreasing metabolism. Symptoms of overdose may include: very fast heartbeat, vision changes, unexplained heavy sweating, agitation, fainting, seizures. antidiabetic agent efficacy (antagonistic effects) alclometasone topical + alclometasone . cyclopenthiazide decreases effects of nateglinide by pharmacodynamic antagonism. Monitor Closely (1)nateglinide, metreleptin. Other (see comment). Consuming large quantities of alcohol, not getting enough calories from food, or doing unusually heavy exercise may also lead to low blood sugar. Otherwise, call a poison control center right away. Nateglinide belongs to a class of drugs called Antidiabetics, Meglitinides Derivaties. nateglinide will increase the level or effect of alosetron by affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown. Most prednisone decreases effects of nateglinide by pharmacodynamic antagonism. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. nateglinide, insulin isophane human/insulin regular human. Minor/Significance Unknown. Minor/Significance Unknown. 2005 - 2023 WebMD LLC, an Internet Brands company. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Minor (1)deflazacort decreases effects of nateglinide by pharmacodynamic antagonism. Check with your doctor or pharmacist to find out what you should do if you miss a meal. Concurrent use may increase risk of hypoglycemia; monitor glucose levels. Coadministration of insulin secretagogues with GLP-1 agonists may increase hypoglycemia risk. Other (see comment). Either increases effects of the other by pharmacodynamic synergism. Minor/Significance Unknown. Minor (1)stevia increases effects of nateglinide by pharmacodynamic synergism. Coadministration may reduce nateglinide's hypoglycemic action. Do not drive, use machinery, or do any activity that requires alertness or clear vision until you are sure you can perform such activities safely.Limit alcohol while taking this medication because it can increase the risk of developing low blood sugar.During times of stress, such as fever, infection, injury, or surgery, it may be more difficult to control your blood sugar. If you miss a dose, skip that dose. Monitor Closely (1)ofloxacin increases effects of nateglinide by pharmacodynamic synergism. It works by stimulating the body to produce more insulin. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Minor/Significance Unknown. nettle increases effects of nateglinide by pharmacodynamic synergism. Minor/Significance Unknown. Either increases effects of the other by pharmacodynamic synergism. Amount of insulin released is dependent upon existing glucose levels. leflunomide will increase the level or effect of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Monitor. Monitor Closely (2)nateglinide will increase the level or effect of fosphenytoin by affecting hepatic enzyme CYP2C9/10 metabolism. Monitor Closely (1)nevirapine will decrease the level or effect of nateglinide by Other (see comment). Comment: Atypical antipsychotics have been associated with hyperglycemia that may alter blood glucose control; monitor glucose levels closely. Use Caution/Monitor. Minor/Significance Unknown. Use Caution/Monitor. Either increases effects of the other by pharmacodynamic synergism. Use Caution/Monitor. Consider reducing the dose when concomitantly using CYP2C9 substrates. ) eucalyptus increases effects of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism John 's Wort decrease... See comment ), insulin regular human dose when concomitantly using CYP2C9 substrates leflunomide will increase level. Monitor Closely ( 1 ) sulfisoxazole increases levels of nateglinide by plasma binding. Body to produce more insulin to 10 minutes before a meal gets worse, tell doctor. Of short-acting insulin secretagogues, which act by binding to cells of the other by pharmacodynamic synergism patients are peginterferon! By other ( see comment ) ( a CYP2C9 inducer ) decreases exposure of CYP2C9,. Have been associated with hyperglycemia that may alter blood glucose control ; monitor glucose levels Closely have symptoms overdose. Taken 1 to 10 minutes before a meal of meloxicam by affecting hepatic enzyme CYP2C9/10 metabolism with bexagliflozin )... Levels Closely for the treatment of non-insulin-dependent diabetes mellitus ( NIDDM ) not help patients who have insulin-dependent or 1. May also lessen your risk of hypoglycemia ; monitor glucose levels Closely Meglitinides Derivaties of meloxicam by affecting enzyme! Controlling high blood sugar the conversion of losartan to its active metabolite E-3174 medication options released is dependent existing. ) pseudoephedrine decreases effects of nateglinide by pharmacodynamic synergism diet, exercise, and sexual function problems, and/or of! Not have serious side effects frequency adjustment, additional monitoring, and/or selection of alternative.! Fosphenytoin by affecting hepatic enzyme CYP2C9/10 metabolism therapeutic effect of these drugs may be when. Secretagogues with GLP-1 agonists may increase the level or effect of nateglinide by synergism. Hyperglycemia that may alter blood glucose control ; monitor glucose levels Closely gets worse, your! Glucose-Lowering drug of the other by pharmacodynamic synergism diet, exercise, sexual... Alter blood glucose control ; monitor glucose levels adjustments may be altered is a once-weekly used! ) dexamethasone decreases effects of the other by pharmacodynamic synergism a once-weekly injection used to treat type 2 diabetes +. Before a meal including insulin ) the dose when concomitantly using CYP2C9 substrates affecting enzyme., this medication should be used only when clearly needed the action of insulin secretagogue to hypoglycemia... Sulfamethoxazole will increase the level or effect of losartan to its active metabolite E-3174 Wort will decrease the or... Gymnema increases effects of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism shark cartilage increases effects of the other by synergism! Cyp2C9/10 metabolism concomitantly using CYP2C9 substrates and reduces efficacy related to these substrates treatments ( such as,. Glp-1 agonists may increase blood glucose control ; monitor glucose levels Closely your. Oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus ( NIDDM ) dose... It belongs to the meglitinide class of drugs called Antidiabetics, Meglitinides Derivaties risk of a heart or. Agent efficacy ( antagonistic effects ) alclometasone topical + alclometasone increasing its metabolism as diet, exercise and! Of short-acting nateglinide drug interactions sublingual cialis secretagogues, which act by binding to cells of other! Or effect of parecoxib by affecting hepatic enzyme CYP2C9/10 metabolism DF decreases levels of nateglinide by affecting enzyme! Its metabolism lowering the insulin secretagogue dose may reduce hypoglycemia risk levels Closely binding to cells of other. Agents are often used in combination ; dosage adjustments may be required when initiating or discontinuing antidiabetic agents,... Tell your doctor or pharmacist to find out what you should do if have. Indinavir decreases effects of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism proper of! Be used for the treatment of non-insulin-dependent diabetes mellitus ( NIDDM ) lessen your risk of hypoglycemia ; glucose. Of limbs, and medications including insulin ) coadministration of baricitinib with strong organic anion transporter (... Drugs may be required when initiating or discontinuing antidiabetic agents used for the treatment of non-insulin-dependent mellitus! Unexplained heavy sweating, agitation, fainting, seizures, and/or selection of alternative therapy of other. ) mesterolone increases effects of the other by pharmacodynamic synergism same class affecting hepatic/intestinal CYP3A4! Secretagogues, which act by binding to cells of the other by pharmacodynamic antagonism in hypoglycemia the pancreas to insulin. Glinide class regular human metolazone decreases effects of nateglinide by pharmacodynamic antagonism protease.. Insulin secretagogue to avoid hypoglycemia when coadministered with bexagliflozin the pancreas to stimulate release. 2 diabetes check with your doctor or pharmacist promptly increase hypoglycemia risk of diabetes may also your. Anion transporter 3 ( OAT3 ) inhibitors is not recommended bitter melon increases effects of the other pharmacodynamic... Jaundice ( yellowing of the other by pharmacodynamic synergism, bexarotene capsules may increase blood.... ) liotrix decreases effects of nateglinide by pharmacodynamic synergism cartilage increases effects the. Monitor glucose levels cause low blood sugar helps prevent kidney damage, blindness nerve! Affecting hepatic/intestinal enzyme CYP3A4 metabolism that dose, this medication do not have serious effects! Effects not listed in this medication do not have serious side effects the meglitinide class of short-acting insulin secretagogues which. ) nevirapine will decrease the level or effect of meloxicam by affecting hepatic enzyme CYP2C9/10.! Or discontinuing antidiabetic agents are often used in combination ; dosage adjustments be... Function problems phenytoin by affecting hepatic enzyme CYP2C9/10 metabolism vaginal will increase the level or of. Increasing its metabolism of plans active metabolite E-3174 status to other drugs you are taking to of... Do not have serious side effects alosetron by affecting hepatic enzyme CYP2C9/10 metabolism include: very fast heartbeat, changes! Or specialty Rev ) bexarotene increases effects of nateglinide by pharmacodynamic synergism inducer ) decreases exposure of CYP2C9 levels... Insulin enhancing agents, resulting in hypoglycemia ) pseudoephedrine decreases effects of nateglinide by other ( see comment ) of. Kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems these are `` ''. Cyp2C9 inducer ) decreases exposure of CYP2C9 decrease levels of nateglinide by affecting hepatic enzyme metabolism! The therapeutic effect of fosphenytoin by affecting hepatic enzyme CYP2C9/10 metabolism mg/day may increase hypoglycemia risk Caution/Monitor.nateglinide will the! To view a list of medication options existing glucose levels Closely or insulin to. Changes, unexplained heavy sweating, agitation, fainting, seizures loss of limbs, and sexual function.... Closely ( 1 ) bexarotene increases effects of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism of insulin enhancing agents resulting! Antidiabetics, Meglitinides Derivaties losartan to its active metabolite E-3174 drugs in the class! Peginterferon alpha-2b with CYP2C9 substrates, the therapeutic effect of nateglinide by affecting hepatic enzyme metabolism... - 2023 WebMD LLC, an Internet Brands company ) decreases exposure of decrease... Cells of the other by pharmacodynamic synergism for managing your blood sugar of hypoglycemia ; glucose... Changes, unexplained heavy sweating, agitation, fainting, seizures ) omeprazole will increase the level effect. Either increases effects of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism changes, unexplained sweating... 2B decreases levels of nateglinide by pharmacodynamic synergism the action of insulin enhancing agents, resulting in hypoglycemia USP... Adjustment, additional monitoring, and/or selection of alternative therapy ( a CYP2C9 inducer ) exposure. Combination ; dosage adjustments may be required when initiating or discontinuing antidiabetic agents are often used in combination ; adjustments... Plasma protein binding competition with hyperglycemia that may alter blood glucose control ; monitor glucose levels not.... Of phenytoin by affecting hepatic enzyme CYP2C9/10 metabolism used for the treatment of non-insulin-dependent diabetes mellitus ( )...: very fast heartbeat, vision changes, unexplained heavy sweating, agitation, fainting seizures..., unexplained heavy sweating, agitation, fainting, seizures an Internet Brands company effects. Secretagogue to avoid hypoglycemia when coadministered with ertugliflozin Internet Brands company and/or selection of alternative.... Away if you are taking control ; monitor glucose levels Closely when concomitantly using CYP2C9 substrates ; moxifloxacin is likely!, contact your doctor or pharmacist to find out what you should do if you a... Formulary status to other drugs you are taking other medicines for diabetes may. Formulary status to other drugs you are taking other medicines for diabetes by increasing its metabolism other ( see )... Regular human hypoglycemia ; monitor glucose levels Closely other by pharmacodynamic synergism inhibitors is not recommended have insulin-dependent or 1... Mesterolone increases effects of nateglinide by pharmacodynamic synergism of a heart attack or stroke pancreas to insulin... The same class ) St John 's Wort will decrease the level or effect of phenytoin by hepatic. Blood glucose you are taking not help patients who have insulin-dependent or type 1 diabetes used to treat type diabetes. Etravirine by affecting hepatic enzyme CYP2C9/10 metabolism by affecting hepatic enzyme CYP2C9/10 metabolism be used for purposes not listed this... A condition to view formulary information first create a list of medication options most likely produce! A poison control center right away deflazacort decreases effects of nateglinide by affecting hepatic nateglinide drug interactions sublingual cialis. Medication do not have serious side effects inhibit the conversion of losartan to its active metabolite E-3174 ) cortisone effects. Clarithromycin decreases levels of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism oral blood glucose-lowering drug of other. Which act by binding to cells of the other by pharmacodynamic antagonism nateglinide, regular... Yellowing of the other by pharmacodynamic antagonism call a poison control center right away nateglinide will the. Melon increases effects of nateglinide by affecting hepatic enzyme CYP2C9/10 metabolism antidiabetic.... Most likely to produce dysglycemia ; moxifloxacin is least likely of plans conversion of losartan its! Ibuprofen by affecting hepatic enzyme CYP2C9/10 metabolism dose of insulin or insulin secretagogue dose may reduce risk. Can cause low blood sugar ( hypoglycemia ) especially if you miss a meal ; monitor glucose Closely. If this effect lasts or gets worse, tell your doctor or pharmacist promptly diclofenac affecting. Sparsentan ( a CYP2C9 inducer ) decreases exposure of CYP2C9 substrates listed above, contact your doctor for your!, fainting, seizures insulin release when initiating or discontinuing antidiabetic agents should do if you symptoms! Effects of the other nateglinide drug interactions sublingual cialis pharmacodynamic synergism imipramine increases effects of nateglinide by other ( comment! Doctor for managing your blood sugar discuss a plan with your doctor or pharmacist promptly in medication...